Edgewise Therapeutics (EWTX) Shares Issued (2020 - 2026)

Edgewise Therapeutics (EWTX) has 7 years of Shares Issued data on file, last reported at $1.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued changed 0.0% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (changed 0.0% YoY), and the FY2025 full-year result was $1.1 million, down 92.56% from the prior year.
• Shares Issued eased to $1.0 million in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $15.4 million in Q4 2024 to a low of $1.0 million in Q1 2025.
• A 5-year average of $4.6 million and a median of $2.0 million in 2025 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued jumped 230.01% in 2022 and sank 92.56% in 2025, its largest moves.
• Tracing EWTX's Shares Issued over 5 years: stood at $10.6 million in 2022, then soared by 36.16% to $14.5 million in 2023, then climbed by 6.38% to $15.4 million in 2024, then slumped by 92.56% to $1.1 million in 2025, then declined by 12.15% to $1.0 million in 2026.
• Business Quant data shows EWTX's Shares Issued at $1.0 million in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q3 2025.